NYSE:MC - Moelis & Company Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $50.38
  • Forecasted Upside: -6.54 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 6 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$53.90
▼ -0.82 (-1.50%)
1 month | 3 months | 12 months
Get New Moelis & Company Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MC

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$50.38
▼ -6.54% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for Moelis & Company in the last 3 months. The average price target is $50.38, with a high forecast of $68.00 and a low forecast of $24.00. The average price target represents a -6.54% upside from the last price of $53.90.

Hold

The current consensus among 8 polled investment analysts is to hold stock in Moelis & Company. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/25/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
3/24/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/22/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 5 hold ratings
  • 2 sell ratings
9/20/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 2 sell ratings
12/19/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 2 sell ratings
3/19/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 2 sell ratings
5/18/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 2 sell ratings
6/17/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 6 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/17/2021Wolfe ResearchUpgradeUnderperform ➝ Peer Perform$63.00Medium
i
4/15/2021JMP SecuritiesReiterated RatingMarket Outperform ➝ Market PerformHigh
i
4/9/2021JMP SecuritiesDowngradeOutperform ➝ Market PerformMedium
i
4/7/2021Morgan StanleyBoost Price TargetEqual Weight$57.00 ➝ $60.00Low
i
3/16/2021Piper SandlerBoost Price Target$58.00 ➝ $68.00Low
i
2/11/2021Morgan StanleyBoost Price TargetEqual Weight$55.00 ➝ $57.00Low
i
1/11/2021Morgan StanleyBoost Price TargetEqual Weight$52.00 ➝ $55.00Medium
i
1/7/2021JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$34.00 ➝ $50.00N/A
i
1/5/2021UBS GroupUpgradeNeutral ➝ Buy$40.00 ➝ $56.00N/A
i
12/16/2020Seaport Global SecuritiesInitiated CoverageNeutralN/A
i
Rating by J. Mitchell at Seaport Global Securities
12/14/2020Morgan StanleyBoost Price TargetEqual Weight$41.00 ➝ $52.00Medium
i
10/27/2020Piper SandlerBoost Price TargetNeutral$37.00 ➝ $41.00Medium
i
Rating by Jeff Harte at Piper Sandler
10/12/2020Morgan StanleyBoost Price TargetEqual Weight$29.00 ➝ $41.00Low
i
10/9/2020JMP SecuritiesBoost Price TargetMarket Outperform$37.00 ➝ $42.00Low
i
10/9/2020Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$40.00Medium
i
10/2/2020UBS GroupUpgradeSell ➝ Neutral$38.00High
i
Rating by Brennan Hawken at UBS Group AG
8/5/2020The Goldman Sachs GroupDowngradeNeutral ➝ Sell$27.00 ➝ $24.00Medium
i
7/30/2020Piper SandlerLower Price TargetNeutral$32.00 ➝ $31.00Medium
i
Rating by Jeff Harte at Piper Sandler
7/30/2020Morgan StanleyLower Price TargetEqual Weight$31.00 ➝ $29.00High
i
7/22/2020Wolfe ResearchInitiated CoverageUnderperform$19.00High
i
7/13/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$34.00 ➝ $27.00High
i
7/10/2020Piper SandlerDowngradeOverweight ➝ Neutral$40.00 ➝ $32.00High
i
7/7/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$20.00 ➝ $26.00High
i
Rating by Ken Worthington at JPMorgan Chase & Co.
4/14/2020UBS GroupDowngradeNeutral ➝ Sell$22.00Low
i
4/9/2020JMP SecuritiesLower Price TargetMarket Outperform$45.00 ➝ $39.00Low
i
4/9/2020Morgan StanleyLower Price TargetEqual Weight$37.00 ➝ $31.00Medium
i
3/25/2020UBS GroupLower Price TargetNeutral$33.00 ➝ $28.00Low
i
3/23/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$20.00Medium
i
2/6/2020JPMorgan Chase & Co.Boost Price TargetOverweight$44.00 ➝ $49.00High
i
2/6/2020Buckingham ResearchBoost Price TargetBuy$39.00 ➝ $41.00High
i
Rating by James Mitchell at Buckingham Research
1/26/2020Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$34.00 ➝ $39.00Low
i
Rating by Michael Brown at Keefe, Bruyette & Woods
12/11/2019Morgan StanleyLower Price TargetEqual Weight$37.00 ➝ $35.00Medium
i
10/9/2019Buckingham ResearchLower Price TargetBuy$44.00 ➝ $39.00Low
i
10/8/2019Morgan StanleyLower Price TargetEqual Weight$41.00 ➝ $39.00Medium
i
7/31/2019Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Market Perform$42.00 ➝ $39.00Low
i
7/11/2019Buckingham ResearchLower Price TargetBuy$53.00 ➝ $44.00Medium
i
7/8/2019Morgan StanleyLower Price TargetEqual Weight$45.00 ➝ $41.00Low
i
4/11/2019Bank of AmericaDowngradeBuy ➝ UnderperformMedium
i
4/8/2019JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$56.00 ➝ $50.00Low
i
1/8/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$59.00 ➝ $46.00Low
i
1/4/2019Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Outperform$43.00Medium
i
12/7/2018Sandler O'NeillUpgradeHold ➝ Buy$45.00Medium
i
Rating by Jeff Harte at Sandler O'Neill
11/6/2018The Goldman Sachs GroupInitiated CoverageBuy$53.00High
i
10/23/2018UBS GroupLower Price TargetNeutral ➝ Neutral$59.00 ➝ $54.00High
i
10/8/2018UBS GroupLower Price TargetNeutral ➝ Neutral$62.00 ➝ $59.00Medium
i
7/24/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$65.00 ➝ $68.00Low
i
7/16/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$59.00 ➝ $65.00Low
i
6/21/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$63.00High
i
6/4/2018Buckingham ResearchBoost Price TargetBuy ➝ Buy$60.00 ➝ $69.00Low
i
4/24/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$60.00 ➝ $63.00High
i
4/24/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$55.00 ➝ $57.00High
i
2/9/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$49.00 ➝ $60.00Medium
i
2/8/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$53.00 ➝ $55.00Low
i
10/26/2017UBS GroupBoost Price TargetNeutral$42.00 ➝ $45.00N/A
i
10/26/2017JMP SecuritiesBoost Price TargetMarket Outperform$44.00 ➝ $47.00N/A
i
10/26/2017Morgan StanleyBoost Price TargetOverweight$45.00 ➝ $49.00N/A
i
7/25/2017Morgan StanleyBoost Price TargetOverweight$39.00 ➝ $45.00High
i
7/25/2017JMP SecuritiesBoost Price TargetMarket Outperform$42.00 ➝ $44.00High
i
7/25/2017Bank of AmericaBoost Price TargetBuy$43.00 ➝ $45.00High
i
7/25/2017UBS GroupReiterated RatingNeutral$40.00 ➝ $42.00High
i
5/15/2017Keefe, Bruyette & WoodsReiterated RatingMarket PerformN/A
i
Rating by Ann Dai at Keefe, Bruyette & Woods
5/5/2017Keefe, Bruyette & WoodsInitiated CoverageMkt Perform ➝ Mkt PerformLow
i
Rating by Ann Dai at Keefe, Bruyette & Woods
5/4/2017Keefe, Bruyette & WoodsUpgradeHold$39.00Low
i
Rating by Ann Dai at Keefe, Bruyette & Woods
12/14/2016Aurel - BGCInitiated CoverageBuy$37.00N/A
i
12/14/2016Bank of AmericaInitiated CoverageBuy$37.00N/A
i
11/20/2016Credit Suisse GroupReiterated RatingNeutral$26.00N/A
i
Rating by Ashley Serrao at Credit Suisse Group AG
10/13/2016Sandler O'NeillDowngradeBuy ➝ Hold$30.00 ➝ $27.00N/A
i
8/4/2016UBS GroupBoost Price TargetNeutral$23.00 ➝ $24.00N/A
i
Rating by Brennan Hawken at UBS Group AG
6/28/2016Credit Suisse GroupReiterated RatingHoldN/A
i
Rating by Ashley Serrao at Credit Suisse Group AG
(Data available from 6/17/2016 forward)
Moelis & Company logo
Moelis & Company operates as an investment banking advisory firm in the United States, Europe, and internationally. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. The company offers its services to public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, and governments. It has strategic alliances with Sumitomo Mitsui Banking Corporation and SMBC Nikko Securities Inc.; and Alfaro, Dávila y Scherer, S.C. The company was founded in 2007 and is headquartered in New York, New York.
Read More

Today's Range

Now: $53.90
$53.19
$55.74

50 Day Range

MA: $53.95
$51.22
$57.08

52 Week Range

Now: $53.90
$28.28
$59.63

Volume

5,080 shs

Average Volume

431,272 shs

Market Capitalization

$3.45 billion

P/E Ratio

15.81

Dividend Yield

4.01%

Beta

1.23

Frequently Asked Questions

What sell-side analysts currently cover shares of Moelis & Company?

The following equities research analysts have issued reports on Moelis & Company in the last year: JMP Securities, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Piper Sandler, Seaport Global Securities, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for MC.

What is the current price target for Moelis & Company?

8 Wall Street analysts have set twelve-month price targets for Moelis & Company in the last year. Their average twelve-month price target is $44.88, suggesting a possible downside of 18.1%. Piper Sandler has the highest price target set, predicting MC will reach $68.00 in the next twelve months. Wolfe Research has the lowest price target set, forecasting a price of $19.00 for Moelis & Company in the next year.
View the latest price targets for MC.

What is the current consensus analyst rating for Moelis & Company?

Moelis & Company currently has 2 sell ratings, 6 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MC, but not buy more shares or sell existing shares.
View the latest ratings for MC.

What other companies compete with Moelis & Company?

How do I contact Moelis & Company's investor relations team?

Moelis & Company's physical mailing address is 399 PARK AVENUE 5TH FLOOR, NEW YORK NY, 10022. The asset manager's listed phone number is 212-883-3800 and its investor relations email address is [email protected] The official website for Moelis & Company is www.moelis.com.